PATENT CLAIM ANALYSIS

Application Number: 15757133
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "266200"]

Abstract:
In one aspect the present disclosure provides a method of sensitizing a cancer patient to chemotherapy by administering a combination therapy comprising; a) a therapeutically effective amount of a compound of formula (I) an enantiomer thereof or a pharmaceutically acceptable salts of any one of the same, and b) a chemotherapeutic agent or a combination of chemotherapeutic agents.

Claim (Index 11):
A method according to  claim 10 , wherein the cancer is selected from the group comprising liver cancer (such as hepatocellular carcinoma), biliary tract cancer, breast cancer (such as none ER+ breast cancer), prostate cancer, colorectal cancer, ovarian cancer, cervical cancer, lung cancer, gastric cancer, pancreatic, bone cancer, bladder cancer, head and neck cancer, thyroid cancer, skin cancer, renal cancer, and oesophagus cancer.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15757189', '12807931', '12218470', '14581610', '11433079']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7308521734682734
- 35 USC 102 Novelty (BERT): 0.5329546765987894
- Combined Prediction Score: 0.711062423781325
- Mean Citation Score: 242.32139
- Max Citation Score: 362.1345
- Similarity Product: 262.9252568530441

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test